{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:07:34Z","timestamp":1793815654536,"version":"4.6.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10800-1","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T14:48:50Z","timestamp":1743518930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Changes in gut microbiome following anti-tuberculosis treatment: a prospective cohort from eastern China"],"prefix":"10.1186","volume":"25","author":[{"given":"Simin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"12","key":"10800_CR1","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1513\/AnnalsATS.201509-632PS","volume":"12","author":"JF Murray","year":"2015","unstructured":"Murray JF, Schraufnagel DE, Hopewell PC. Treatment of tuberculosis. A historical perspective. Ann Am Thorac Soc. 2015;12(12):1749\u201359.","journal-title":"Ann Am Thorac Soc"},{"key":"10800_CR2","unstructured":"World Health Organization. Global tuberculosis report [Internet]. 2023 [cited 2025 Jan 10]."},{"key":"10800_CR3","unstructured":"World Health Organization. Global tuberculosis report [Internet]. 2024 [cited 2025 Jan 10]."},{"issue":"6","key":"10800_CR4","first-page":"444","volume":"30","author":"T Li","year":"2017","unstructured":"Li T, Zhang H, Wang LX, Pang Y, Du X. Description and factors affecting the referral of presumptive tuberculosis patients in China. Biomed Environ Sci BES. 2017;30(6):444\u20139.","journal-title":"Biomed Environ Sci BES"},{"key":"10800_CR5","first-page":"4","volume":"17","author":"M Giorgia","year":"2021","unstructured":"Giorgia M, Mark M, Antje B. Microbiome-immune interactions in tuberculosis. PLoS Pathog. 2021;17:4.","journal-title":"PLoS Pathog"},{"key":"10800_CR6","doi-asserted-by":"crossref","unstructured":"Suprabhat M, Nikhilesh J, Subhasree S, Santi P SB: Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings. J Nutr Biochem 2018;61(0):111\u201328.","DOI":"10.1016\/j.jnutbio.2018.07.010"},{"issue":"5717","key":"10800_CR7","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1126\/science.1104816","volume":"307","author":"F Backhed","year":"2005","unstructured":"Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307(5717):1915\u201320.","journal-title":"Science"},{"issue":"6141","key":"10800_CR8","doi-asserted-by":"crossref","first-page":"1237439","DOI":"10.1126\/science.1237439","volume":"341","author":"JJ Faith","year":"2013","unstructured":"Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, Clemente JC, Knight R, Heath AC, Leibel RL, et al. The long-term stability of the human gut microbiota. Science. 2013;341(6141):1237439.","journal-title":"Science"},{"issue":"1","key":"10800_CR9","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1038\/s41467-020-19701-0","volume":"11","author":"KL Bowerman","year":"2020","unstructured":"Bowerman KL, Rehman SF, Vaughan A, Lachner N, Budden KF, Kim RY, Wood DLA, Gellatly SL, Shukla SD, Wood LG, et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun. 2020;11(1):5886.","journal-title":"Nat Commun"},{"issue":"1","key":"10800_CR10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/1751-7915.13761","volume":"15","author":"ST Wang","year":"2022","unstructured":"Wang ST, Yang LY, Hu HY, Lv LX, Ji ZK, Zhao YM, Zhang H, Xu M, Fang RF, Zheng L, et al. Characteristic gut microbiota and metabolic changes in patients with pulmonary tuberculosis. Microb Biotechnol. 2022;15(1):262\u201375.","journal-title":"Microb Biotechnol"},{"issue":"2","key":"10800_CR11","first-page":"321","volume":"32","author":"K Majewski","year":"2018","unstructured":"Majewski K, Agier J, Kozlowska E, Brzezinska-Blaszczyk E. Status of Cathelicidin Ll-37, Cytokine Tnf, and vitamin D in patients with pulmonary tuberculosis. J Biol Reg Homeos Ag. 2018;32(2):321\u20135.","journal-title":"J Biol Reg Homeos Ag"},{"issue":"4","key":"10800_CR12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jaci.2017.02.004","volume":"139","author":"KF Chung","year":"2017","unstructured":"Chung KF. Airway microbial dysbiosis in asthmatic patients: a target for prevention and treatment? J Allergy Clin Immunol. 2017;139(4):1071\u201381.","journal-title":"J Allergy Clin Immunol"},{"key":"10800_CR13","doi-asserted-by":"crossref","first-page":"1323723","DOI":"10.3389\/fimmu.2024.1323723","volume":"15","author":"C Yinghui","year":"2024","unstructured":"Yinghui C, Xin L, Guangliang B, Nannan Z, Danfeng L, Xiaomeng Z, Min L, Kang L, Hong L. Gut microbiome, T cell subsets, and cytokine analysis identify differential biomarkers in tuberculosis. Front Immunol. 2024;15:1323723.","journal-title":"Front Immunol"},{"issue":"1","key":"10800_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12866-024-03275-8","volume":"24","author":"H MeiQing","year":"2024","unstructured":"MeiQing H, Xia W, JiaMin Z, Lin S, Hafiz Muhammad I, Duan L, JunWei C, HuaJie Z, Fan Y. Gut bacterial and fungal dysbiosis in tuberculosis patients. BMC Microbiol. 2024;24(1):141.","journal-title":"BMC Microbiol"},{"issue":"2","key":"10800_CR15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","volume":"23","author":"A Tostmann","year":"2008","unstructured":"Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WC, van der Ven AJ, Dekhuijzen R. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J Gastroenterol Hepatol. 2008;23(2):192\u2013202.","journal-title":"J Gastroenterol Hepatol"},{"key":"10800_CR16","doi-asserted-by":"crossref","first-page":"633396","DOI":"10.3389\/fmicb.2021.633396","volume":"12","author":"MR Ticlla","year":"2021","unstructured":"Ticlla MR, Hella J, Hiza H, Sasamalo M, Mhimbira F, Rutaihwa LK, Droz S, Schaller S, Reither K, Hilty M, et al. The sputum microbiome in pulmonary tuberculosis and its association with disease manifestations: a cross-sectional Study. Front Microbiol. 2021;12:633396.","journal-title":"Front Microbiol"},{"issue":"9","key":"10800_CR17","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.7150\/ijms.53492","volume":"18","author":"D Lin","year":"2021","unstructured":"Lin D, Wang X, Li Y, Wang W, Li Y, Yu X, Lin B, Chen Y, Lei C, Zhang X, et al. Sputum microbiota as a potential diagnostic marker for multidrug-resistant tuberculosis. Int J Med Sci. 2021;18(9):1935\u201345.","journal-title":"Int J Med Sci"},{"key":"10800_CR18","doi-asserted-by":"crossref","unstructured":"John OS, Nontuthuko EM, Petrus BF. Mycobacterium tuberculosis, antimicrobials, immunity, and lung-gut microbiota crosstalk: current updates and emerging advances. Ann N Y Acad Sci. 2020;1467(1):21\u201347.","DOI":"10.1111\/nyas.14300"},{"key":"10800_CR19","doi-asserted-by":"crossref","unstructured":"Svedlund J, Sj\u00f6din I, Dotevall G: GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33(2):129\u201334.","DOI":"10.1007\/BF01535722"},{"key":"10800_CR20","doi-asserted-by":"crossref","first-page":"1247772","DOI":"10.3389\/fpubh.2023.1247772","volume":"11","author":"HW Kim","year":"2023","unstructured":"Kim HW, Min J, Ko Y, Oh JY, Jeong YJ, Lee EH, Yang B, Koo HK, Lee SS, Park JS, et al. Risk of loss to follow-up among tuberculosis patients in South Korea: whom should we focus on? Front Public Health. 2023;11:1247772.","journal-title":"Front Public Health"},{"issue":"9","key":"10800_CR21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/tropicalmed7090244","volume":"7","author":"VP Giri","year":"2022","unstructured":"Giri VP, Giri OP, Pandey PT, Mishra KN, Prasad RS, Lal PK. The characteristics and patterns of drug-resistant pulmonary tuberculosis in Eastern India. Trop Med Infect Dis. 2022;7(9):244.","journal-title":"Trop Med Infect Dis"},{"issue":"3","key":"10800_CR22","doi-asserted-by":"crossref","first-page":"e0061521","DOI":"10.1128\/spectrum.00615-21","volume":"9","author":"DM Cao","year":"2021","unstructured":"Cao DM, Liu WH, Lyu N, Li BX, Song WB, Yang YX, Zhu JL, Zhang ZG, Zhu BL. Gut mycobiota dysbiosis in pulmonary tuberculosis patients undergoing anti-tuberculosis treatment. Microbiol Spectrum. 2021;9(3): e0061521.","journal-title":"Microbiol Spectrum"},{"key":"10800_CR23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fcimb.2019.00090","volume":"9","author":"YF Hu","year":"2019","unstructured":"Hu YF, Feng YQ, Wu JN, Liu F, Zhang ZG, Hao YN, Liang SH, Li BX, Li J, Lv N, et al. The gut microbiome signatures discriminate healthy from pulmonary tuberculosis patients. Front Cell Infect Microbiol. 2019;9:90.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10800_CR24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jinf.2018.08.006","volume":"78","author":"YF Hu","year":"2019","unstructured":"Hu YF, Yang QT, Liu B, Dong J, Sun LL, Zhu YF, Su HX, Yang J, Yang F, Chen XC, et al. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs. J Infect. 2019;78(4):317\u201322.","journal-title":"J Infect"},{"issue":"5","key":"10800_CR25","doi-asserted-by":"crossref","first-page":"e13068","DOI":"10.1111\/eci.13068","volume":"49","author":"SF Huang","year":"2019","unstructured":"Huang SF, Yang YY, Chou KT, Fung CP, Wang FD, Su WJ. Systemic proinflammation after Mycobacterium tuberculosis infection was correlated to the gut microbiome in HIV-uninfected humans. Eur J Clin Invest. 2019;49(5):e13068.","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10800_CR26","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4269\/ajtmh.21-0310","volume":"105","author":"SL Huey","year":"2021","unstructured":"Huey SL, Yu EA, Finkelstein JL, Brannon PM, Glesby MJ, Bonam W, Russell DG, Mehta S. Nutrition, inflammation, and the gut microbiota among outpatients with active tuberculosis disease in India. Am J Trop Med Hyg. 2021;105(6):1645\u201356.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10800_CR27","doi-asserted-by":"crossref","first-page":"e0245534","DOI":"10.1371\/journal.pone.0245534","volume":"16","author":"A Khaliq","year":"2021","unstructured":"Khaliq A, Ravindran R, Afzal S, Jena PK, Akhtar MW, Ambreen A, Wan YJY, Malik KA, Irfan M, Khan IH. Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting. PLoS One. 2021;16(1):e0245534.","journal-title":"PLoS One"},{"issue":"1","key":"10800_CR28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12887-019-1782-2","volume":"19","author":"WR Li","year":"2019","unstructured":"Li WR, Zhu Y, Liao Q, Wang ZL, Wan CM. Characterization of gut microbiota in children with pulmonary tuberculosis. BMC Pediatr. 2019;19(1):445.","journal-title":"BMC Pediatr"},{"key":"10800_CR29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3389\/fphys.2017.00822","volume":"8","author":"M Luo","year":"2017","unstructured":"Luo M, Liu Y, Wu PF, Luo DX, Sun Q, Zheng H, Hu R, Pandol SJ, Li QF, Han YP, et al. Alternation of Gut Microbiota in Patients with Pulmonary Tuberculosis. Front Physiol. 2017;8:822.","journal-title":"Front Physiol"},{"issue":"1","key":"10800_CR30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/1462-2920.14015","volume":"20","author":"A Maji","year":"2018","unstructured":"Maji A, Misra R, Dhakan DB, Gupta V, Mahato NK, Saxena R, Mittal P, Thukral N, Sharma E, Singh A, et al. Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers. Environ Microbiol. 2018;20(1):402\u201319.","journal-title":"Environ Microbiol"},{"key":"10800_CR31","doi-asserted-by":"crossref","first-page":"103374","DOI":"10.1016\/j.ebiom.2021.103374","volume":"67","author":"CC Naidoo","year":"2021","unstructured":"Naidoo CC, Nyawo GR, Sulaiman I, Wu BG, Turner CT, Bu K, Palmer Z, Li YH, Reeve BWP, Moodley S, et al. Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis. EBioMedicine. 2021;67:103374.","journal-title":"EBioMedicine"},{"issue":"5","key":"10800_CR32","doi-asserted-by":"crossref","first-page":"e0008230","DOI":"10.1371\/journal.pntd.0008230","volume":"14","author":"S Namasivayam","year":"2020","unstructured":"Namasivayam S, Diarra B, Diabate S, Sarro YDS, Kone A, Kone B, Tolofoudie M, Baya B, Diakite MT, Kodio O, et al. Patients infected with Mycobacterium africanum versus Mycobacterium tuberculosis possess distinct intestinal microbiota. PLoS Negl Trop Dis. 2020;14(5):e0008230.","journal-title":"PLoS Negl Trop Dis"},{"key":"10800_CR33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijid.2021.08.064","volume":"111","author":"WP Shi","year":"2021","unstructured":"Shi WP, Hu Y, Ning Z, Xia F, Wu MY, Hu YOO, Chen C, Prast-Nielsen S, Xu BA. Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: a pilot study. Int J Infect Dis. 2021;111:313\u201321.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10800_CR34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12890-019-0981-9","volume":"19","author":"WP Shi","year":"2019","unstructured":"Shi WP, Hu Y, Zheng XB, Ning Z, Wu MY, Xia F, Prast-Nielsen S, Hu YOO, Xu B. Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study. BMC Pulm Med. 2019;19(1):211.","journal-title":"BMC Pulm Med"},{"key":"10800_CR35","first-page":"A6087","volume":"201","author":"W Su","year":"2020","unstructured":"Su W, Huang S, Yang Y, Wang F, Fung C. Gut microbiota dysbiosis contributes to the development of the constitutional symptoms in non-HIV infected patients with mycobacterium tuberculosis infection. Am J Respir Crit Care Med. 2020;201:A6087.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10800_CR36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41467-021-21475-y","volume":"12","author":"MF Wipperman","year":"2021","unstructured":"Wipperman MF, Bhattarai SK, Vorkas CK, Maringati VS, Taur Y, Mathurin L, McAulay K, Vilbrun SC, Francois D, Bean J, et al. Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis. Nat Commun. 2021;12(1):1141.","journal-title":"Nat Commun"},{"issue":"1","key":"10800_CR37","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1038\/s41598-017-10346-6","volume":"7","author":"MF Wipperman","year":"2017","unstructured":"Wipperman MF, Fitzgerald DW, Juste MAJ, Taur Y, Namasivayam S, Sher A, Bean JM, Bucci V, Glickman MS. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed. Sci Rep. 2017;7(1):10767.","journal-title":"Sci Rep"},{"issue":"1","key":"10800_CR38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3349\/ymj.2022.63.1.34","volume":"63","author":"H Yoon","year":"2022","unstructured":"Yoon H, Park YS, Shin CM, Kim N, Lee DH. Gut microbiome in probable intestinal tuberculosis and changes following anti-tuberculosis treatment. Yonsei Med J. 2022;63(1):34\u201341.","journal-title":"Yonsei Med J"},{"issue":"7606","key":"10800_CR39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/534182a","volume":"534","author":"K Faust","year":"2016","unstructured":"Faust K, Raes J. Host-microbe interaction rules of the game for microbiota. Nature. 2016;534(7606):182\u20133.","journal-title":"Nature"},{"issue":"2","key":"10800_CR40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/ijmm.IJMM_19_373","volume":"37","author":"P Pushpanathan","year":"2019","unstructured":"Pushpanathan P, Mathew GS, Selvarajan S, Seshadri KG, Srikanth P. Gut microbiota and its mysteries. Indian J Med Microbiol. 2019;37(2):268\u201377.","journal-title":"Indian J Med Microbiol"},{"key":"10800_CR41","doi-asserted-by":"crossref","unstructured":"Y\u00fcksel E, Voragen AGJ, Kort R. The pectin metabolizing capacity of the human gut microbiota. Crit Rev Food Sci Nutr. 2024:1\u201323.","DOI":"10.1080\/10408398.2024.2400235"},{"issue":"9","key":"10800_CR42","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325\u201340.","journal-title":"J Lipid Res"},{"key":"10800_CR43","doi-asserted-by":"crossref","first-page":"112352","DOI":"10.1016\/j.biopha.2021.112352","volume":"145","author":"R Mirzaei","year":"2022","unstructured":"Mirzaei R, Dehkhodaie E, Bouzari B, Rahimi M, Gholestani A, Hosseini-Fard SR, Keyvani H, Teimoori A, Karampoor S. Dual role of microbiota-derived short-chain fatty acids on host and pathogen. Biomed Pharmacother = Biomed Pharmacother. 2022;145:112352.","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"key":"10800_CR44","doi-asserted-by":"crossref","first-page":"111817","DOI":"10.1016\/j.biopha.2021.111817","volume":"141","author":"R Ranjbar","year":"2021","unstructured":"Ranjbar R, Vahdati SN, Tavakoli S, Khodaie R, Behboudi H. Immunomodulatory roles of microbiota-derived short-chain fatty acids in bacterial infections. Biomed Pharmacother = Biomed Pharmacother. 2021;141:111817.","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"issue":"2","key":"10800_CR45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3444","volume":"20","author":"A Trompette","year":"2014","unstructured":"Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20(2):159\u201366.","journal-title":"Nat Med"},{"issue":"33","key":"10800_CR46","first-page":"12073","volume":"63","author":"Y Sun","year":"2023","unstructured":"Sun Y, Zhang S, Nie Q, He H, Tan H, Geng F, Ji H, Hu J, Nie S. Gut firmicutes: Relationship with dietary fiber and role in host homeostasis. 2023;63(33):12073\u201388.","journal-title":"Gut firmicutes: Relationship with dietary fiber and role in host homeostasis"},{"issue":"9","key":"10800_CR47","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.chom.2023.07.008","volume":"31","author":"CKI Jordan","year":"2023","unstructured":"Jordan CKI, Brown RL, Larkinson MLY, Sequeira RP, Edwards AM, Clarke TB. Symbiotic Firmicutes establish mutualism with the host via innate tolerance and resistance to control systemic immunity. Cell Host Microbe. 2023;31(9):1433-1449.e1439.","journal-title":"Cell Host Microbe"},{"issue":"12","key":"10800_CR48","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.cmi.2021.04.025","volume":"27","author":"N Buetti","year":"2021","unstructured":"Buetti N, Marschall J, Timsit JF, Atkinson A, Kronenberg A, Sommerstein R. Distribution of pathogens and antimicrobial resistance in bacteraemia according to hospitalization duration: a nationwide surveillance study in Switzerland. Clinical microbiology and infection\u202f: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021;27(12):1820\u20135.","journal-title":"Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"6","key":"10800_CR49","first-page":"e01926","volume":"10","author":"S Li","year":"2022","unstructured":"Li S, Guo J, Liu R, Zhang F, Wen SA, Liu Y, Ren W, Zhang X, Shang Y, Gao M. Predominance of Escherichia-Shigella in gut microbiome and its potential correlation with elevated level of plasma tumor necrosis factor alpha in patients with tuberculous meningitis. Microbiol Spectrum. 2022;10(6):e01926-22.","journal-title":"Microbiol Spectrum"},{"issue":"7\u20138","key":"10800_CR50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurol.2019.07.007","volume":"175","author":"F M\u00e9cha\u00ef","year":"2019","unstructured":"M\u00e9cha\u00ef F, Bouchaud O. Tuberculous meningitis: challenges in diagnosis and management. Revue neurologique. 2019;175(7\u20138):451\u20137.","journal-title":"Revue neurologique"},{"issue":"8","key":"10800_CR51","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3390\/nu14081668","volume":"14","author":"Y Li","year":"2022","unstructured":"Li Y, Zhao L, Hou M, Gao T, Sun J, Luo H, Wang F, Zhong F, Ma A. Lactobacillus casei Improve anti-tuberculosis drugs-induced intestinal adverse reactions in rat by modulating gut microbiota and short-chain fatty acids. Nutrients. 2022;14(8):1668.","journal-title":"Nutrients"},{"issue":"3","key":"10800_CR52","first-page":"359","volume":"4","author":"L Chen","year":"2022","unstructured":"Chen L, Zhang G. Ifnar gene variants influence gut microbial production of palmitoleic acid and host immune responses to tuberculosis. 2022;4(3):359\u201373.","journal-title":"Ifnar gene variants influence gut microbial production of palmitoleic acid and host immune responses to tuberculosis"},{"issue":"1","key":"10800_CR53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12931-023-02652-7","volume":"25","author":"Z Yuan","year":"2024","unstructured":"Yuan Z, Kang Y, Mo C, Huang S, Qin F, Zhang J, Wang F, Jiang J, Yang X, Liang H, et al. Causal relationship between gut microbiota and tuberculosis: a bidirectional two-sample Mendelian randomization analysis. Respir Res. 2024;25(1):16.","journal-title":"Respir Res"},{"issue":"1","key":"10800_CR54","first-page":"2406379","volume":"16","author":"ME Panzetta","year":"2024","unstructured":"Panzetta ME, Valdivia RH. Akkermansia in the gastrointestinal tract as a modifier of human health. 2024;16(1):2406379.","journal-title":"Akkermansia in the gastrointestinal tract as a modifier of human health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10800-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10800-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10800-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T14:50:26Z","timestamp":1743519026000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10800-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10800"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10800-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Jiangsu Center for Disease Control and Prevention (JSJK2020-B009 -01). Written informed consent was obtained from study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"453"}}